Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Zhao (Beijing, China), Y. He (Beijing, China), S. Guo (Beijing, China), Y. Yan (Beijing, China), Z. Wang (Beijing, China), J. Ye (Beijing, China), J. Zhang (Beijing, China), Y. Wang (Beijing, China), X. Pang (Kaifeng, China), Z. Jing (Beijing, China), Z. Han (Beijing, China). Comparative analysis of the plasma metabolomics in rodent models of pulmonary hypertension and patients with IPAH shows different metabolic signatures. 5052

Member's Comments

No comment yet.

Related content which might interest you: Comparative analysis of routine biochemistry data and neurohormonal markers in patients with different forms of pulmonary hypertension Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010 Proteomic profiling identifies an exercise signature in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Genetic findings in patients with different forms of pulmonary hypertension Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020 Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Identification of clinical phenotypes using cluster analyses in COPD patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 New rare variant associations with distinct phenotypes in patients with pulmonary arterial hypertension revealed with Bayesian inference. Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020 iTRAQ-based proteomic analysis reveals mitochondrial 'damage'-associated molecular patterns are involved in pulmonary inflammation in Lypopolysaccharide-induced acute lung injury Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 COPD prediction by using imaging and genetic profiles Source: International Congress 2014 – Pathways to personalised medicine in obstructive lung disease Year: 2014 Proteomic analysis of plasma from COPD patients and smoking control subjects Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 A comparative proteomic profiling of the human erythrocyte membrane in COPD patients Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Novel method of expressing serum biomarkers profiling in COPD patients: The heatmap-clinical pattern profile Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 The use of microarray analysis of gene signalling to determine heterogeneity of COPD exacerbation phenotypes Source: ERS Lung Science Conference 2016 Year: 2016 Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes Source: Eur Respir J 2014; 44: 985-993 Year: 2014 Impact of the state of endothelium on clinical and functional parameters in COPD patients with arterial hypertension. Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 Application of omics technologies to the identification of biomarkers for COPD Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Simultaneous analysis of clinical markers for predicting increased lung function fluctability in stable asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 A network analysis of clinical characteristics of patients with COPD: partial results. Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients Year: 2018 Molecular, metabolic and histological profiling reveal smoke worsens inflammation in a mouse model of viral COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 251s Year: 2005